CHSJ

Curr Health Sci J, vol. 45, no. 4, 2019

Combination of Olanzapine Pamoate with Melatonin and Metformin: Quantitative Changes in Rat Adipose Tissue

[Original Paper]

I.C. MIRON (1), F. POPESCU (2), V. ENACHESCU (3), O.M. CRISTEA (4), E.C. STOICANESCU (5), E. AMZOIU (2), M. AMZOIU (2), F.D. POPESCU (6)

1) Department of Oncology, CFR Hospital, Craiova, Romania 2) Department of Pharmacology, University of Medicine and Pharmacy of Craiova, Romania 3) Department of Family Medicine, University of Medicine and Pharmacy of Craiova, Romania 4) Department of Microbiology, University of Medicine and Pharmacy of Craiova, Romania 5) Department of Neonatology, Rm. Vâlcea County Hospital, Romania 6) Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania


Abstract:

Olanzapine is one of the atypical antipsychotics widely used in the treatment of schizophrenia and has been associated with metabolic changes as adverse effects, including hyperglycemia, dyslipidemia, and weight gain. In a batch of adult female Wistar rats, we studied the prolonged-release intramuscular olanzapine pamoate induced quantitative changes of visceral and subcutaneous adipose tissue. We also assessed the effects of the combinations of olanzapine pamoate with melatonin, metformin, and melatonin plus metformin, administered by gastric gavage. A higher mean weight of the visceral and subcutaneous adipose tissue per animal was noted in the olanzapine pamoate exposed group compared to controls. The association with melatonin, metformin, or the combination of melatonin with metformin attenuated the olanzapine-induced adipose deposit tissue growth. The effect was more pronounced for the combination of olanzapine with melatonin and metformin. Because most of the results were not statistically significant we can deduce that in the chronic experiment, adaptive type modifications of the receptors on which both olanzapine and melatonin act can occur.


Keywords: Adipose tissue, rats, olanzapine pamoate, melatonin, metformin



Corresponding: Florica Popescu, Department of Pharmacology, University of Medicine and Pharmacy of Craiova, Romania, e-mail: prof_floricapopescu@hotmail.com Oana Mariana Cristea, Department of Pharmacology, University of Medicine and Pharmacy of Craiova, Romania, e-mail: ioneteoana@yahoo.com


DOI 10.12865/CHSJ.45.04.05 - Download PDF
current issue cover Download cover
Download contents

Journal archive